October 20, 2025 a 01:00 pm
COR: Fundamental Ratio Analysis - Cencora, Inc.
The stock analysis of Cencora, Inc. suggests a solid performance with a promising outlook in the pharmaceutical distribution sector. Known for its robust U.S. Healthcare Solutions and International Healthcare Solutions segments, Cencora is well-positioned within the market. Investors may find this stock appealing due to its strategic presence in pharmaceutical distribution and various healthcare services.
Fundamentals Rating
Cencora, Inc. shows a balanced set of fundamental metrics with strengths in certain areas like discounted cash flow and return on equity.
| Category | Score | Score Bar |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 5 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
Analysis of historical scores shows consistency with a stable overall score reflecting firm fundamentals.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-10-17 | 3 | 5 | 5 | 4 | 1 | 2 | 1 |
| Previous | 0 | 5 | 5 | 4 | 1 | 2 | 1 |
Analyst's Price Targets
The current consensus among analysts suggests moderate confidence with a 'Buy' rating, supported by strong price targets.
| High | Low | Median | Consensus |
|---|---|---|---|
| 354 | 330 | 337 | 339.5 |
Analyst Sentiment
Analyst sentiment points towards a favorable outlook with a majority leaning towards buying the stock.
| Recommendation | Count | Distribution |
|---|---|---|
| Buy | 28 | |
| Hold | 14 | |
| Sell | 1 |
Conclusion
Cencora, Inc., with its strong footing in the healthcare distribution sector, presents a good investment opportunity. While the stock shows a high DCF and ROE, its low debt to equity and price to book could be areas of concern. The positive analyst sentiment and projected price targets further enhance its appeal. Caution is advised due to possible market volatility and sector-specific risks.